Phase II evaluation of docetaxel plus one-day oral estramustine phosphate in the treatment of patients with androgen independent prostate carcinoma

Victoria J. Sinibaldi, Michael A. Carducci, Sandra Moore-Cooper, Menachem Laufer, Marianna Zahurak, Mario A. Eisenberger

Research output: Contribution to journal › Article › peer-review

143 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II evaluation of docetaxel plus one-day oral estramustine phosphate in the treatment of patients with androgen independent prostate carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences